Skip to main content
IntroMedic Co., Ltd. logo

IntroMedic Co., Ltd. — Investor Relations & Filings

Ticker · 150840 ISIN · KR7150840007 KO Manufacturing
Open in API
Filings indexed 442 across all filing types
Latest filing 2023-10-31 Capital/Financing Update
Country KR South Korea
Listing KO 150840

About IntroMedic Co., Ltd.

http://www.intromedic.com/

IntroMedic Co., Ltd. is a medical device company that develops, manufactures, and distributes capsule endoscopy products. Established in 2004, the company's core offering is the MiroCam® capsule endoscope system. This system is designed as a tool for the detection of abnormalities within the small bowel in both adult and pediatric patients from two years of age. IntroMedic operates through a global network of partner companies to distribute its medical equipment.

Recent filings

Filing Released Lang Actions
전환사채(해외전환사채포함)발행후만기전사채취득(제12회차)
Capital/Financing Update Classification · 100% confidence The document is a regulatory filing from Intromedic regarding the acquisition of convertible bonds before maturity (specifically the 12th series). It details the bond type, acquisition amount, acquisition date, and the reason (call option exercise). This falls under capital structure changes and financing updates, specifically related to debt instruments. Given the specific nature of the transaction (bond buyback/repayment), it fits best under the 'CAP' (Capital/Financing Update) category.
2023-10-31 Korean
기타시장안내(실질심사 대상여부 결정을 위한 조사기간 연장 안내)
Regulatory Filings Classification · 100% confidence The document is a short regulatory notice from the Korea Exchange regarding the extension of the investigation period for the eligibility review of Intromedic. It does not contain financial statements or specific corporate reports, but rather serves as a formal regulatory announcement regarding market status and trading suspension. As it is a regulatory notification that does not fit into specific categories like M&A or dividends, it falls under the RNS (Regulatory Filings) category.
2023-10-19 Korean
기타시장안내(상장적격성 실질심사 대상결정 기한 안내)
Delisting Announcement Classification · 100% confidence The document is a short notice from the stock exchange regarding the timeline for a 'listing eligibility review' (상장적격성 실질심사) for the company IntroMedic. It is a regulatory announcement concerning the status of the company's listing, which does not fit into specific categories like M&A, dividends, or financial reports. Therefore, it falls under the general regulatory filing category.
2023-09-27 Korean
[기재정정]사업보고서 (2022.12)
Audit Report / Information Classification · 100% confidence The document is a formal 'Audit Report' (감사보고서) for Intromedic Co., Ltd. for the fiscal year ending December 31, 2022. It includes the independent auditor's report, financial statements (balance sheet, income statement, statement of changes in equity, cash flow statement), and notes. It is not an Annual Report (10-K) as it focuses specifically on the audit results and financial statements rather than the broader company activity report. It is not an announcement (RPA) because it contains the full financial data and audit opinion. FY 2022
2023-09-22 Korean
[기재정정]감사보고서제출(2022사업연도)
Audit Report / Information Classification · 100% confidence The document is a formal regulatory filing titled '감사보고서 제출' (Submission of Audit Report) which details a correction (정정신고) to a previously submitted audit report. It provides specific financial data, including audit opinions (changing from 'disclaimer of opinion' to 'unqualified opinion'), balance sheet figures, and income statement details for the fiscal year. As it is a formal regulatory disclosure of audit results and financial statements, it falls under the Audit Report / Information category. FY 2022
2023-09-21 Korean
기타시장안내(형식적 상장폐지 사유 해소 및 매매거래정지 지속 안내)
Delisting Announcement Classification · 100% confidence The document is an official announcement from the Korea Exchange (KRX) regarding Intromedic. It details the resolution of a formal delisting cause related to audit opinions but simultaneously announces the initiation of a substantive review for listing eligibility and the continuation of a trading suspension. This is a regulatory announcement regarding the status of a company's listing, which fits the 'Regulatory Filings' (RNS) category as it is a specific market notice from the exchange.
2023-09-21 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.